Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

179 POSTS 0 COMMENTS

atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

Psygen Industries Ltd letter to Health Canada re: SAP

The Psilocybin Supply Chain: An Evidence-Based Review

Somerville, Massachusetts, Passes Measure to Decriminalize Psychedelics

1...8910...18 Page 9 of 18

EDITOR PICKS

Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could...

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

Psygen Industries Ltd letter to Health Canada re: SAP

The Psilocybin Supply Chain: An Evidence-Based Review

Sept/Oct 2020 Newsletter

November 2020 Newsletter

July 2020 Newsletter

June 2020 Newsletter

CLINICAL RESEARCH ASSOCIATE